NASDAQ

Monopar Therapeutics Inc. (MNPR)

♥ 604 Thanks from members

Live price chart, market sentiment, and community perspectives for Monopar Therapeutics Inc. (NASDAQ: MNPR).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: David J. MazzoLeadership: David J. Mazzo (CEO)Leadership: Anna KazanchyanHolder: Monopar Therapeutics InsidersHolder: Institutional InvestorsValidiveCamsirubicinMNPR-101#MNPR#Monopar Therapeutics#Biotech Stock#Oncology Therapeutics#Clinical Stage